Overview

Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the efficacy and safety of administration of linaclotide acetate in patients with chronic constipation.
Phase:
Phase 2
Details
Lead Sponsor:
Ironwood Pharmaceuticals, Inc.
Treatments:
Linaclotide